Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
247.50    -2.50 (-1.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £224.83m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Product Launch

6 Apr 2010 11:26

Concurrent Technologies Plc

Product Launch New Computer Product Augments Competitive Position

Concurrent Technologies Plc ("Concurrent" or the "Company"), a world leading specialist in the design and manufacture of high-end embedded computer products, is pleased to announce the launch of a new range of VME embedded computer boards; the VP 717/08X.

This range of boards is based on the recently launched Intel® Coreâ„¢ i7 processor which has been introduced for the mobile embedded market and is based on the very latest 32nm technology. The processor introduces key features which will be of benefit to an even wider range of applications within the defence market than previously suited to Intel® processor technology. Consequently, VP 717/08X customers will benefit from improved performance per Watt of power, a sophisticated memory cache as well as much faster memory performance and improved graphics capability. Given the high performance and increased functionality of the Coreâ„¢i7, the boards are particularly well suited for CPU intensive processing applications within the defence, homeland security, industrial control, and transportation market sectors. Commercial and extended temperature versions are available today, and a compatible range of ruggedized, conduction-cooled or air-cooled versions will be available shortly.

Glen Fawcett, Managing Director, Concurrent Technologies, commented:

"Concurrent remains committed to producing products which will be available for many years and this is no exception. We only use processors from Intel's embedded roadmap which guarantees availability for a minimum of 7 years; this goes a long way to meeting the needs of our customers' requirements for long life cycle products while simultaneously providing them with enhanced processing capabilities.

The VP 717/08x, being an upgrade to an existing board,will appeal to both existing customers for technology refreshes, as well as new customers who can take advantage of the latest features of the Coreâ„¢ i7technology to standardize more of their application on Intel®based hardware, thereby reducing their overall cost of ownership."

6 April, 2010Enquiries:Concurrent Technologies Plc 01206 752 626

Glen Fawcett, Managing Director

Haggie Financial LLP 020 7417 8989

Nicholas Nelson

Nominated AdviserBrewin Dolphin Investment Banking 0845 213 4726

Neil Baldwin/Neil McDonald

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

Note to Editors:

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets. Using Intel® processors, including the latest Intel® Coreâ„¢ i7 processors, Intel® Xeon®, Atomâ„¢ and Coreâ„¢ 2 dual-core processors, the Company offers a wide range of computer products which are designed to be compliant with the most stringent industry specifications including those for products used in extremely harsh environments.

For more information on Concurrent and its products please visit http:// www.cct.co.uk

vendor
Date   Source Headline
19th Jun 20237:00 amRNSUpdate on Audited Annual Results
12th Jun 20237:00 amRNSSignificant Systems Win
9th Jun 20235:11 pmRNSNotification of Major Holdings
7th Jun 20237:00 amRNSNew Distributor Agreement
5th Jun 20237:00 amRNSNotice of Results
24th Mar 20237:00 amRNSNew Product Announcement
21st Mar 20237:00 amRNSReseller Agreement
4th Jan 20237:00 amRNSPost-Close Trading Update
14th Dec 20227:00 amRNSPartnership Agreement
28th Oct 20227:00 amRNSIssue of Share options and PDMR dealing
5th Oct 20227:00 amRNSConcurrent Technologies Enters the Systems Market
26th Sep 20227:00 amRNSInterim Results
12th Sep 20227:00 amRNSNotice of Interim Results
24th Aug 202210:29 amRNSHolding(s) in Company
24th Aug 202210:27 amRNSHolding(s) in Company
19th Aug 202212:06 pmRNSHolding(s) in Company
13th Jul 20227:00 amRNSSupply Agreement
29th Jun 202212:55 pmRNSResult of AGM
30th May 20227:00 amRNSPosting of Annual Report & Notice of AGM
23rd May 20222:46 pmRNSIssue of Share options and PDMR dealing
12th May 20227:00 amRNSResults for the year ended 31 December 2021
11th May 20227:00 amRNSInvestor Presentation
9th May 20227:00 amRNSConfirmation of Results Date and Board Appointment
24th Mar 202212:44 pmRNSNotice of Results
9th Mar 202210:36 amRNSContract Award
25th Feb 20227:00 amRNSProduct Announcement
21st Feb 20227:00 amRNSBoard Changes
26th Jan 20227:00 amRNSProduct Announcement
5th Jan 20227:00 amRNSPost-Close Trading Update
23rd Nov 20217:07 amRNSIssue of Share Options and PDMR Dealing
27th Sep 20213:12 pmRNSBoard Changes
7th Sep 20217:00 amRNSBoard Changes
7th Sep 20217:00 amRNSInterim Results
1st Sep 20211:20 pmRNSNotice of Results
10th Aug 202112:05 pmRNSHolding(s) in Company
4th Aug 20217:00 amRNSProduct Announcement
21st Jul 20217:00 amRNSBoard Changes
8th Jul 202111:15 amRNSHolding(s) in Company
23rd Jun 202111:58 amRNSIssue of share options and PDMR dealing
15th Jun 20214:19 pmRNSResult of AGM
15th Jun 202112:34 pmRNSAGM Statement
20th May 20217:00 amRNSPosting of Annual Report & Notice of AGM
12th May 20219:00 amRNSBoard Changes
12th Apr 20217:00 amRNSFinal Results
25th Mar 202110:50 amRNSNotification of Results
10th Mar 20217:00 amRNSSecond Interim Dividend
16th Dec 20207:00 amRNSPre-Close Trading Update
13th Nov 202011:58 amRNSDirector/PDMR Shareholding
5th Nov 20207:00 amRNSLaunch of high performance Advanced MC Board
21st Oct 20204:02 pmRNSTreasury Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.